Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 46, Issue 3, 2013, Pages 335-339

  De Almeida, Adriana Araújo ^a   Mesquita, Cristiane Suemi Shinobu ^b   Svidzinski, Terezinha Inez Estivalet ^b   De Oliveira, Kelly Mari Pires ^a  

^a UNIVERSIDADE FEDERAL DA GRANDE DOURADOS   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Amphotericin B; Candida; Candidemia; Candiduria; Fluconazole

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD ANALYSIS; BRAZIL; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CHILD; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; FEMALE; FUNGAL CELL CULTURE; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; HUMAN; INFANT; INTENSIVE CARE UNIT; MALE; NURSING HOME; PRESCHOOL CHILD; SCHOOL CHILD; TRACHEA; TRACHEA MUCUS; URINALYSIS; WARD;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BRAZIL; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; FLUCONAZOLE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; YOUNG ADULT;

EID: 84880000311     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0074-2012     Document Type: Article

References (33)

1. Fridkin SK. The changing face of fungal infections in health care settings. Clin Infect Dis 2005; 41:1455-1460.
2. Azie N, Neofytos D, Pfaller M., Meier-Kriesche HU, Quan SP, Horn D. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. Diagn Microbiol Infect Dis 2012; 73:293-300.
3. Colombo AL, Guimarães T. Epidemiologia das infecções hematogênicas por Candida spp. Rev Soc Bras Med Trop 2003; 36:599-607.
4. Alonso-Valle H., Acha O, Garcia-Palomo JD, Fariñas-Alvarez C, Femández-Mazarrasa C, Fariñas MC. Candidemia in terciary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 2003; 22:254-257.
5. st. ed. Philadelphia: Churchill Livingstone, 2003; p. 195-239.
6. Chi HW, Yang YS, Shang S.T., Chen KH, Yeh KM, Chang FY, et al Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcome. J Microbiol Immun Infec 2011; 44:369-375.
7. Colombo AL, Nucci M, Salomão R, Branchini M.L., Richtmann R., Derossi A, et al High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis 1999; 34:281-286.
8. Ortega M, Marco F, Soriano A., Almela M, Martínez JA, López J, et al. Candida Species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008. J Hosp Infect 2011; 77:157-161.
9. Schmalreck AF, Willinger B, Haase G., Blum G, Lass-Flörl C, Fegeier W, et al. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multicentre study. Mycoses 2012; 55: e124-el37.
10. Tortorano AM, Prigitano A, Dho G., Grancini A, Passera M, ECMM-FIMUA Study Group. Antifungal susceptibility profiles of Candida isolates from a prospective survey of invasive fungal infections in Italian intensive care units. J Med Microbiol 2012; 61:389-393.
11. Ashley ESD, Lewis R, Lewis J.S., Martin C., Andes D. Pharmacology of Systemic Antifungal Agents. Clin Infec Dis 2006; 43:S28-S39.
12. Furnaleto MC, Rota JF, Quesada RMB, Furnaleto-Maia L, Rodrigues R, Oda S., et al. Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period. Rev Soc Bras Med Trop 2011; 44:595-599.
13. Pfaller MA, Diekema DJ, Jones R.N., Sader HS, Fluit AC, Hollis RJ, et al International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39:3254-3259.
14. Giolo MP, Svidzinski TIE. Fisiopatogenia, epidemiologia e diagnóstico laboratorial da candidemia. J Bras Patol Med Lab 2010; 46:225-234.
15. Yarrow D. Methods for the isolation, maintenance and identification of yeasts. In: CP Kurtzman, JW Fell, editors. The yeast, a taxonomie study. Elsevier: New York; 1998. p. 77-99.
16. rd. ed. Wayne: CLSI; 2008a.
17. 1 Informational Supplement, M27-S3. Wayne: CLSI; 2008b.
18. Yang YL, Wang AH, Wang C.W., Cheng WT, Li SY, Lo HJ Suscetibilities to amphotericin B and fluconazole of Candida species in Taiwan surveillance of antimicrobial resistance of yeasts 2006. Diag Microbiol Infect Dis 2008; 61:175-180.
19. Chang MR, Correia FP, Costa L.C., Xavier PCN, Palhares DB, Taira D.L., et al. Candida bloodstream infection: data from a teaching hospital in Mato Grosso do Sul, Brazil. Rev Inst Med Trop S Paulo 2008; 50:265-268.
20. Yamamoto ACA, Paula CR, Dias L.B., Tadano T., Martins ERM, Amadio JVRS, et al. Epidemiological and clinical characteristics of nosocomial candidiasis in university hospitals in Cuiabá - Mato Grosso, Brazil. Rev Iberoam Micol 2012; 29: 164-168.
21. Guimarães T., Nucci M, Mendonçã JS, Martinez R, Brito LR, Silva N, et al. Epidemiology and predictors of a poor outcome in elderly patients with candidemia. Int J Infect Dis 2012; 16:e442-e447.
22. Hube B. From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans. Curr Opin Microbiol 2004; 7:336-341.
23. Talarmin JP, Boutoille D, Tattevin P., Dargère S, Weinbreck P., Ansart S, et al. Epidemiology of candidemia: a one-year prospective observational study in the west of France. Med Mai Infect 2009; 39:877-885.
24. Hinrichsen SL, Falcão E, Vilella TAS, Rêgo L, Lira C., Almeida L, et al. Candidemia em hospital terciário do nordeste do Brasil. Rev Soc Bras Med Trop 2008; 41:394-398.
25. Delgado J, Calvo N, Gomis A., Pérez-Flores I, Rodríguez A, Ridao N, et al. Candiduria in renal transplant recipients: incidence, clinical repercussion, and treatment indication. Transplant Proc 2010; 42:2944-2946.
26. Jain M, Dogra V, Mishra B., Thakur A, Loomba PS, Bhargava A. Candiduria in catheterized intensive care unit patients: emerging microbiological trends. Indian J Pathol Microbiol 2011; 54:552-555.
27. Edmond MB, Wallace SE, McClish D.K., Pfaller MA, Jones RN, Wenzel RP Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29:239-244.
28. Tortorano AM, Pen J, Bernhardt H., Klingspor L, Kibbler CC, Faure O, et al Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23:317-322.
29. Colombo AL, Nucci M, Park B.J., Nouér SA, Arthington-Skagg B, Matta D.A., et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006;44:2816-2823.
30. Wisplinghoff H, Bischoff T, Tallent S.M., Seifert H., Wenzel RP, Edmond MB Nosocomial bloodstream infections in US hospitals: analysis of 25,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-317.
31. Pfaller MA, Messer SA, Moet G.J., Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to equinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 2011; 38:65-69.
32. Kiraz N, Dag I, Oz Y., Yamac M, Kiremitci A, Kasifoglu N. Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata. J Microbiol Methods 2010; 82: 136-140.
33. Singla N, Gulati N, Kaistha N., Chander J. Candida colonization in urine samples of ICU patients: determination of etiology, antifungal susceptibility testing and evaluation of associated risk factors. Mycopathologia 2012; 174:149-155.